Clinical Trials
Trial explorer
Search registered peptide and longevity trials by compound, condition, country, recruitment status, phase and sponsor.
- 4 trials tracked
- Multi-country
- Status and last update shown
Biolivon does not run trials and cannot enrol you in one. If a study interests you, take the identifier to your doctor — eligibility is a clinical judgement. A terminated or withdrawn trial is often as informative as a completed one, which is why we keep them listed.
Showing 4 of 4 tracked trials. A registered trial is a plan, not a result — registration says nothing about whether a compound works.
- NCT00000001Active, not recruitingPhase 3InterventionalUpdated 12 Jun 2026
Long-term cardiometabolic outcomes with GLP-1 receptor agonism
- Condition
- Obesity with established cardiovascular disease
- Sponsor
- Industry sponsor
- Enrolment
- 17,604
- Countries
- United States, Germany, India
- NCT00000002RecruitingPhase 3InterventionalUpdated 19 Jul 2026
Dual incretin agonism in type 2 diabetes with chronic kidney disease
- Condition
- Type 2 diabetes; chronic kidney disease
- Sponsor
- Industry sponsor
- Enrolment
- 1,400
- Countries
- United States, Japan, India
- NCT00000003RecruitingPhase 3InterventionalUpdated 15 Jul 2026
Triple receptor agonist in obesity — phase 3 programme
- Condition
- Obesity
- Sponsor
- Industry sponsor
- Enrolment
- 2,100
- Countries
- United States, United Kingdom
- NCT00000004CompletedPhase 3InterventionalUpdated 28 Feb 2026
Cardiolipin-targeted peptide in primary mitochondrial myopathy
- Condition
- Primary mitochondrial myopathy
- Sponsor
- Industry sponsor
- Enrolment
- 218
- Countries
- United States